Cellyan Biotechnology Co., Ltd - Ordinary Shares, par value $0.001 per share (HKPD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / Ordinary Shares, par value $0.001 per share
Symbol
HKPD on Nasdaq
Shares outstanding
11,000,000
Price per share
$0.80
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
73,590
Total reported value
$60,667
% of total 13F portfolios
0%
Share change
+61,473
Value change
+$50,678
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellyan Biotechnology Co., Ltd - Ordinary Shares, par value $0.001 per share (HKPD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Wang Liying 65% $11,511,500 7,150,000 Liying Wang 06 Oct 2025
Wong Lap Sun 57% $7,369,054 6,244,961 Lap Sun Wong 31 Mar 2025
Atlantic Health Century International Group 5.6% $729,063 617,850 Atlantic Health Century International Group 31 Mar 2025
Pacific Health Century International Group 5.6% $729,063 617,850 Pacific Health Century International Group 31 Mar 2025

As of 31 Dec 2025, 4 institutional investors reported holding 73,590 shares of Cellyan Biotechnology Co., Ltd - Ordinary Shares, par value $0.001 per share (HKPD). This represents 0.67% of the company’s total 11,000,000 outstanding shares.

Institutional Holders of Cellyan Biotechnology Co., Ltd - Ordinary Shares, par value $0.001 per share (HKPD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 73,590 $60,667 +$50,678 $0.82 4
2025 Q3 12,117 $17,812 -$81,942 $1.47 2
2025 Q2 73,561 $93,517 +$30,366 $1.28 6
2025 Q1 51,681 $55,817 +$55,817 $1.08 4